Evaluated articles
A list by ScreenIT
Articles that have been evaluated by ScreenIT.
Showing page 420 of 1181 pages of list content
-
Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies
This article has 40 authors:Reviewed by ScreenIT
-
The challenge of SARS-CoV-2 environmental monitoring in schools using floors and portable HEPA filtration units: Fresh or relic RNA?
This article has 8 authors:Reviewed by ScreenIT
-
Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern
This article has 27 authors:Reviewed by ScreenIT
-
-
Viral RNA Load and Infectivity of SARS-CoV-2 in Paired Respiratory and Oral Specimens from Symptomatic, Asymptomatic, or Postsymptomatic Individuals
This article has 9 authors:Reviewed by ScreenIT
-
-
-
Differentiating between infectious and non-infectious influenza A virus and coronavirus RNA levels using long-range RT-qPCR
This article has 12 authors:Reviewed by ScreenIT
-
The primacy of meeting public university students’ essential needs in the wake of COVID-19: An overdue higher education priority
This article has 6 authors:Reviewed by ScreenIT
-
Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases
This article has 23 authors:Reviewed by ScreenIT
-
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
This article has 3 authors:Reviewed by ScreenIT
-
Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide
This article has 7 authors:Reviewed by ScreenIT
-
Rising incidence of carbapenem resistant isolates: an Argentinian hospital’s experience. More trouble in the aftermath of the COVID-19 pandemic
This article has 12 authors:Reviewed by ScreenIT
-
Effectiveness of non-pharmaceutical measures (NPIs) on COVID-19 in Europe: A systematic literature review
This article has 11 authors:Reviewed by ScreenIT
-
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients
This article has 33 authors:Reviewed by ScreenIT
-
Genomic landscape of the SARS-CoV-2 pandemic in Brazil suggests an external P.1 variant origin
This article has 7 authors:Reviewed by ScreenIT
-
Frontline Healthcare workers suffering from psychosomatic disorders during COVID-19 (a pandemic) – A Systematic review
This article has 4 authors:Reviewed by ScreenIT
-
A prototype vaccination model for endemic Covid-19 under waning immunity and imperfect vaccine take-up
This article has 2 authors:Reviewed by ScreenIT
-
A Mathematical Model for Stability Analysis of Covid like Epidemic/Endemic/Pandemic
This article has 3 authors:Reviewed by ScreenIT
-
Low But Recoverable Markers of Humoral Immune Response to BNT162b2 in Elderly LTCF Residents Five to Seven Months After Two-Dose Vaccination
This article has 8 authors:Reviewed by ScreenIT